Psychiatric Times Vol 23 No 6

FDA Committees Examine Concerns About Psychiatric Drugs Used by Children

May 01, 2006

The use of psychiatric medications in children, including antidepressants (such as selective serotonin reuptake inhibitors) and drugs used to manage attention-deficit/hyperactivity disorder, are continuing to be reviewed by the FDA.

Psychotropic Drugs: Brain and Plasma Pharmacokinetics and the Therapeutic Window

May 01, 2006

Administering drug dosages that are clinically effective while causing minimal side effects is a challenge for physicians. The latest data on antipsychotics, antidepressants, and other psychotropic drugs in relation to brain occupancy and plasma levels are reviewed here.

Psychopharmacologic Therapy in Pregnancy: Effects on Newborns

May 01, 2006

There is a tendency to avoid psychiatric medications during pregnancy, but the high prevalence of psychiatric disorders in pregnant women means that women and their physicians must make impromptu decisions regarding the initiation or continuation of drug therapy.